For example, fetuin-A therapy in rats subjected to middle cerebral artery occlusion reduced brain infarct volume in a dose-dependent manner [69]; however, there were conflicting data from a European case-cohort study in which higher plasma fetuin-A levels were associated with increased risk of future ischemic stroke [70]. The gene discussed is AHSG; the disease is brain infarction.